Khaitan, Debevoise, Platinum, JSA act on 3% acquisition by Capital International in Intas Pharma

PE Firm Capital International has bought 3% stake in Intas Pharmaceuticals from ChrysCapital , for an estimated value of ₹690 crore ($107 million).

Loading content, please wait...

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com